metaPreg - Naratriptan during pregnancy

Naratriptan updated on 09-22-2019

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	0.50 [0.14, 1.77]	0%	3 studies	56,846	161	not evaluable	ROB	-
Major congenital malformations	0.31 [0.06, 1.63]	0%	2 studies	86	139	not evaluable	ROB	-
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions	1.02 [0.71, 1.46]	0%	2 studies	701	242	not evaluable	ROB	-
Elective/induced termination of pregnancy	0.91 [0.44, 1.87]	0%	2 studies	160	247	not evaluable	ROB	-
Late intrauterine deaths (> 22 weeks) / Stillbirths	0.79 [0.10, 5.99]	0%	2 studies	19	247	not evaluable	ROB	-